Phase 2 N=45 A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Primary: Date of Clinical Cure — 2; 2; 15; 10 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=104 Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale
Erythema · Rosacea
Primary: Inter-rater Reliability of the Clinician Erythema Assessment (CEA) Scale — 0.908 Kendall's W
Phase 2 N=294 A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
Neuralgia, Postherpetic
Primary: Change From Baseline in the Average Pain Intensity Score at Week 12 — 6.13; 6.04; 6.05; -1.42 Score on a scale
Phase 2 N=79 Study Evaluating Bapineuzumab In Alzheimer Disease Subjects
Alzheimer Disease
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 16; 22; 28; 1 participants
Phase 3 N=32 PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
Healthy
Primary: Prostate-specific Antigen (PSA) — 0.8; 0.9; 0.7; 0.4 ng/mL
N/A N=257 Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
HIV Infections
Primary: Confirmed Virologic Failure at or Prior to Week 48 — 95; 105; 34; 23 participants — p=0.133
Phase 3 N=395 Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
Early Rheumatoid Arthritis
Primary: Percentage of Participants With 28-Joint Disease Activity Score of C-reactive Protein (DAS28[CRP]) Low Disease Activity at Week 26 — 42.9; 44.0; 56.6; 60.2 percentage of…
Phase 4 N=183 Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
Blood Pressure
Primary: Sitting Systolic Blood Pressure on Automated Measurement — 127.2; 134.1 mmHg
Phase 4 N=38 Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis
Lumbar Spinal Stenosis
Primary: Mean Change in VAS — 2.52; 0.06 units on a scale — p=<0.05
Phase 2 N=107 Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)
Acne Vulgaris
Primary: Proportion of Patients With Success According to the Dichotomized IGA Scale Based on Facial Assessments 12 Weeks After the First Treatment. Success is Defined as an…
Phase 2 N=20 Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy
Pancreatic Cancer
Primary: Overall Survival Rate at 6 Months — 58 percentage of participants
Phase 2 N=35 Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
Melanoma
Primary: Response Rate (RR) — 1; 2; 1; 8 participants
N/A N=2 Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
Pyoderma Gangrenosum · Crohn's Disease · Ulcerative Colitis
Primary: The Efficacy of Infliximab in Pyoderma Gangrenosum in Adult Subjects Who Have Inflammatory Bowel Disease — 1 participants
Phase 1 N=64 Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
Rosacea · Erythema
Primary: Percentage of Responders With at Least a 2-Grade Decrease From Baseline in Both Clinician Erythema Assessment (CEA) and Subject's Self Assessment (SSA) at Day 1 — 15.6…
N/A N=267 Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
Refractive Ametropia
Primary: Monocular Visual Acuity — -0.044; -0.060 LogMAR score